Chairman of Zhejiang Shuangyuan Technology (688623.SH) proposed to repurchase the company's shares for an amount of 50 to 80 million yuan.
Shuangyuan Technology (688623.SH) announced that the actual controller, chairman, and general manager of the company, Zheng Jian, proposed that the company use the excess funds raised from the initial public offering of RMB ordinary shares to repurchase a portion of the company's issued RMB ordinary shares (A shares) through the Shanghai Stock Exchange trading system in a centralized bidding trading manner. The repurchased shares will be used for employee stock ownership plans or equity incentives at a suitable time in the future. The total amount of the repurchase funds will be no less than 50 million yuan and no more than 80 million yuan.
Zhejiang Shuangyuan Technology (688623.SH) announced that the company's actual controller, chairman, and general manager Zheng Jian proposed to use the excess funds raised from the initial public offering of RMB ordinary shares through a centralized bidding trading method on the Shanghai Stock Exchange trading system to repurchase a portion of the company's issued RMB ordinary shares (A shares), and the repurchased shares will be used in the future when appropriate for an employee stock ownership plan or equity incentive. The total amount of the repurchase funds shall not be less than RMB 50 million (inclusive) and not exceed RMB 80 million (inclusive).
Related Articles

HING YIP HLDGS (00132) enters into a financial lease agreement for certain designated heating equipment and facilities.

Foshan Haitian Flavouring and Food (03288) invested 4,999,900 yuan to repurchase 137,700 A shares on July 22nd.

Shanghai Fosun Pharmaceutical (02196) has its controlling shareholder Fosun High Technology released a pledge of 69 million A-shares.
HING YIP HLDGS (00132) enters into a financial lease agreement for certain designated heating equipment and facilities.

Foshan Haitian Flavouring and Food (03288) invested 4,999,900 yuan to repurchase 137,700 A shares on July 22nd.

Shanghai Fosun Pharmaceutical (02196) has its controlling shareholder Fosun High Technology released a pledge of 69 million A-shares.

RECOMMEND





